×
Customize
?
Start
Cancer Types
Quick Links
Events
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
MPN
Beth Fand Incollingo
At the annual MPN Heroes event, Dr. David Fajgenbaum, who discovered a treatment for his own rare disorder, shared insights on turning hope into action when faced with adversity.
Katie Kosko
Here is a list of the recent trial initiations that occurred within the myeloproliferative neoplasm cancer space.
Jessica Skarzynski and Katie Kosko
Former NHL referee Kerry Fraser opens up about living with an incurable cancer that he refuses to let sideline him.
Debu Tripathy, M.D.
Where does hope lie when it comes to improving the treatment landscape for rare cancers?
Kristie L. Kahl
After almost a decade with no new treatments, Inrebic offers patients with myelofibrosis new hope for the future.
Marilyn Fenichel
Collecting data about cancer through registries can help experts detect trends and patterns, leading to better care for patients.
Kristie L. Kahl
The Food and Drug Administration approved Inrebic as the first new treatment in nearly a decade for patients with myelofibrosis.
Kerry Fraser
During an interview with the “CURE Talks Cancer” podcast, retired NHL referee Kerry Fraser discussed what it is like going through treatment for essential thrombocythemia.
Kerry Fraser
Retired NHL referee Kerry Fraser explained how rest and exercise both factor into his “new normal” after receiving a diagnosis of essential thrombocythemia in 2017.
Kerry Fraser
Retired NHL referee Kerry Fraser shares his advice for coping with a new diagnosis after receiving his own in 2017.